Detalhe da pesquisa
1.
Vitamin D supplementation in children and young adults with persistent proteinuria secondary to glomerular disease.
Pediatr Nephrol
; 38(3): 749-756, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852656
2.
A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial.
Pediatr Nephrol
; 37(11): 2547-2557, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35237863
3.
Novel genetic testing model: A collaboration between genetic counselors and nephrology.
Am J Med Genet A
; 185(4): 1142-1150, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33475249
4.
Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research.
J Am Soc Nephrol
; 30(12): 2427-2435, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732612
5.
LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
Pediatr Nephrol
; 34(11): 2343-2350, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31250206
6.
Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis.
Pediatr Nephrol
; 33(11): 2151-2159, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30003313
7.
The use of renal replacement therapy in critically ill pediatric small bowel transplantation candidates and recipients: Experience from one center.
Pediatr Transplant
; 19(4): E88-92, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25818994
8.
Suppression of iron-regulatory hepcidin by vitamin D.
J Am Soc Nephrol
; 25(3): 564-72, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24204002
9.
Review of childhood genetic nephrolithiasis and nephrocalcinosis.
Front Genet
; 15: 1381174, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38606357
10.
Prospective Study of the Multisite Spread of a Medication Safety Intervention: Factors Common to Hospitals With Improved Outcomes.
Am J Med Qual
; 39(1): 21-32, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127682
11.
Correlates of parathyroid hormone concentration in hemodialysis patients.
Nephrol Dial Transplant
; 28(6): 1516-25, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23348879
12.
Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients.
Nephrol Dial Transplant
; 28(7): 1936-45, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23045431
13.
Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients.
Am J Nephrol
; 35(2): 198-208, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22286821
14.
Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease.
Nephrol Dial Transplant
; 27(7): 2899-907, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22207323
15.
Hemoglobin level and survival in hemodialysis patients with polycystic kidney disease and the role of administered erythropoietin.
Am J Hematol
; 87(8): 833-6, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22641426
16.
Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis.
Pharmacoepidemiol Drug Saf
; 21(11): 1232-9, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22996597
17.
Ironing out the phosphorus problem.
Kidney Int
; 77(10): 845-7, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20431575
18.
Successful treatment of calcific uremic arteriolopathy in a pediatric dialysis patient.
Pediatr Nephrol
; 25(2): 357-62, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19885686
19.
The crossroad of RAAS modulation, inflammation, and oxidative stress in dialysis patients: light at the end of the tunnel?
J Am Soc Nephrol
; 23(2): 189-91, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22241894
20.
Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.
Nat Rev Nephrol
; 14(1): 57-70, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29176657